BIOREMIA aims to improve the patient quality of life by minimizing infection rates of medical implants. Implant-related infections caused by bacterial biofilms are a major cause of implant rejection, with high economic and social associated costs. Bacteria growing in biofilm are 100 to 1000 times less susceptible to antimicrobials than planktonic bacteria.
Since antibiotic treatments are controversially and ineffective for bacterial biofilm, the best infection control approach is to develop novel preventive measures which specifically focus on the inhibition of both bacterial adhesion and biofilm formation, for instance by acting on the implant material itself.
BIOREMIA aims to tackle this problem by proposing innovative material-based solutions with enhanced antibacterial and antifouling functionality that will result in improved biological acceptance of implants for bone-related applications (orthopedics and dentistry). We will use state of the art materials and surface modification technologies designed to potentially limit the initial stages of bacterial adhesion, as well as biofilm formation.
This approach requires highly skilled researchers who have a deep understanding of antibacterial materials, their fabrication and properties, and possess the necessary skills to convert knowledge and ideas into better medical devices that are expected to improve patients’ quality of life and mitigate the economic burden to health systems.
BIOREMIA offers 15 PhD student / Early Stage Researcher (ESR) positions, spread across 11 beneficiary institutions from 10 European countries (Germany, Austria, Italy, Sweden, Greece, UK, Spain, Ireland, France, and Switzerland). These are prestigious and highly competitive positions, which will allow the young researchers to participate in an excellent inter-disciplinary training programme comprising international schools, workshops, and secondments at academic as well as industrial institutions of the network.